Gordon respects netizens’ view of his alleged ‘monopoly’ on Dengvaxia probe
DECEMBER 14, 2017
Sen .Richard Gordon at the Senate probe into Dengvaxia, the dengue vaccine procured and used for an immunization program during the Aquino administration.
INQUIRER PHOTO/LYN RILLON
“They can say anything. It’s a free country.”
Senator Richard Gordon has this to say against netizens criticizing the way he handled last Wednesday’s Senate blue ribbon committee investigation into the Dengvaxia fiasco, which was attended by former President Benigno Aquino III and some of his Cabinet officials.
“It’s their (netizens’) right to say that. I respect them,” Gordon said in a phone interview on Friday.
Some netizens observed that Gordon had “dominated” and “monopolized” the hearing when Aquino and some of his former officials faced the Senate panel.
READ: Minor disruptions in Senate Dengvaxia probe irk Gordon
Without directly referring to the Senate probe, Aquino’s former spokesperson Abigail Valte tweeted while the hearing was ongoing: “Why invite resource persons when you don’t let them finish what they’re saying?”
Gordon, however, apologized to the critics, adding that the committee just needed someone who would just lay the facts of the case for the investigation to run smoothly.
Asked if he thinks it was unfair for some people to accuse him of monopolizing the hearing, Gordon said, “I think it’s lack of knowledge or understanding that somebody has got to lay the predicate or the facts of the case, and the issues involved and I think we did that.”
The senator said he even got feedback from some people he did not identify, asking him why he was “kind” toward Aquino during the probe.
“In fact, a lot of people are saying, “Why were you so kind to President Aquino?” Gordon said.
Aquino and some former cabinet secretaries were blamed for allowing the implementation of the P3.5-billion anti-dengue immunization program using Dengvaxia during his term. The Health department said it had been administered to over 700,000 patients, mostly children.
Some years later, French pharmaceutical giant, Sanofi Pasteur, admitted that the Dengvaxia vaccine might be potentially harmful to people not previously exposed to dengue virus. /jpv
RELATED STORY
Hontiveros calls for ‘more democratic’ Dengvaxia probe at Senate
